GlassScriptPhysician profile
John James Rommel
NPI 1205061678
$263,399.97
in general payments reported to CMS, 2019-2025
25 companies · $6,946 in 2025
The $6,946 reported for 2025 was more than what 75% of Advanced Heart Failure and Transplant Cardiology providers received nationally (typical 2025 total: $1,046).
See the full distribution for Advanced Heart Failure and Transplant Cardiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $327 · 2021: $31K · 2022: $41K · 2023: $106K · 2024: $54K · 2025: $6,946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $123K · Travel and Lodging: $24K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Food and Beverage: $5,181 · Consulting Fee: $4,725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $123,050.00 |
| Travel and Lodging | $23,627.86 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,230.00 |
| Food and Beverage | $5,180.67 |
| Consulting Fee | $4,725.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $211,276.79 | 2019-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $21,605.95 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20,382.29 | 2021-2023 | Jardiance |
| Lilly USA, LLC | $2,860.00 | 2022-2024 | Jardiance |
| Abbott Laboratories | $1,833.71 | 2019-2025 | Amplatzer Amulet, Assurity, Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $1,359.09 | 2022-2025 | General - Therapies, Lux-Dx Insertable Cardiac Monitor |
| Biotronik INC. | $1,333.33 | 2019-2020 | |
| Cvrx, INC. | $643.07 | 2024-2025 | Barostim Neo System |
| Inari Medical, INC. | $482.32 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $425.52 | 2022-2025 | Reveal Linq, Azure Xt Dr Mri Surescan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $253.60 | 2019-2025 | Lifevest |
| Pfizer INC. | $171.28 | 2019-2024 | |
| Actelion Pharmaceuticals US, INC. | $124.46 | 2024 | Uptravi, Opsumit |
| Alnylam Pharmaceuticals INC. | $118.41 | 2019-2020 | |
| Irhythm Technologies, INC. | $93.21 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $75.68 | 2019 | |
| Corvista Health, INC. | $73.98 | 2025 | Corvista System |
| Livanova USA, INC. | $72.91 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $58.47 | 2022-2024 | Eliquis |
| Merck Sharp & Dohme LLC | $37.17 | 2022 | |
| Novo Nordisk INC | $29.68 | 2025 | Wegovy |
| Heartflow, INC. | $29.25 | 2023 | Ffrct |
| Chiesi USA, INC. | $27.27 | 2022 | |
| Procyrion, INC. | $18.64 | 2025 | Aortix System |
| Astrazeneca Pharmaceuticals LP | $13.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Rommel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.